FDA
-
-
-
-
-
-
-
Amedica Corporation Announces Pricing of $15,000,000 Public Offering of Units Consisting of Convertible Preferred Stock and Warrants
-
-
-
-
-
-
-
Amedica (AMDA) Granted Extension by NASDAQ to Regain Compliance with NASDAQ Listing Rule
-
-
-
-
-
-
-
AMEDICA Announces Participation in Australian Spine Conference
-
-
-
-
-
-
-
Amedica (AMDA) Announces 1-for-12 Reverse Stock Split; to Trade on Split-Adjusted Basis on Friday, November 10
-
-
-
-
-
-
-
Amedica Announces Adjournment of Special Meeting of Stockholders
-
-
-
-
-
-
-
Amedica (AMDA) Reports Prelim. Q4 Revenue of $3.6M
-
-
-
-
-
-
-
Amedica Announces Delayed Filing of Annual Report on Form 10-K and Receipt of Nasdaq Letter
-
322,978 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

